| Accession |
PRJCA007704 |
| Title |
Lung cancer targeted therapy |
| Relevance |
Lung cancer |
| Data types |
Transcriptome or Gene expression
|
| Organisms |
Homo sapiens
Homo
|
| Description |
RNA-sq on osimertinib-sensitive and osimertinib resistant cell lines |
| Sample scope |
Monoisolate |
| Release date |
2022-01-24 |
| Publication |
| PubMed ID |
Article title |
Journal name |
DOI |
Year |
| 35197546
|
Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling
|
Communications Biology
|
10.1038/s42003-022-03111-7
|
2022
|
|
|
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| National Natural Science Foundation of China (NSFC)
|
General Program
|
81672287
|
|
|
|
| Submitter |
Li
Li (dpyyhxlili@tmmu.edu.cn)
|
| Organization |
Army Medical University |
| Submission date |
2021-12-24 |
